OrganaBio Expands Rapid PBMC Processing to San Diego at Excellos Labs
OrganaBio launches time-sensitive PBMC isolation in San Diego, extending rapid clinical sample processing to one of the largest cell and gene therapy hubs in the country
Read the full articleYou might also wanna read
Distributed Biomanufacturing: Rethinking Production and Logistics for Autologous Cell Therapies
Centralized manufacturing is not scalable for autologous cell therapies, but pure point-of-care models are not ready for scale. As this roun
Parallel Bio relocates to Bay Area with $30M to replace animal drug testing with organoids
Parallel Bio co-CEOs Robert DiFazio and Juliana Hilliard use organoids to test drugs, raising $30M and relocating to the Bay Area from Bosto
bizjournals.com·24d ago
Cell- and Virus-Bank Characterization in Product Development: A Risk-Based, Phase-Appropriate Framework for Quality Control
The breadth of cell substrates, raw-material inputs, and manufacturing platforms in clinical development is broader than what current guidan
Insilico's AI-discovered lung fibrosis drug enters Phase III
Rentosertib will test whether Insilico's end-to-end AI drug discovery thesis can survive late-stage clinical scrutiny.
Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing
Consultants from ProPharma express optimism about the trajectory of cell and gene therapy despite technical and logistical difficulties rema
Shilpa Biologicals brings ADC manufacturing capacity to Dharwad, India
The announcement from the Indian CDMO came during the BIO International Convention in San Diego, California.
Comments
Sign in to join the conversation.
No comments yet. Be the first.